Prostate Cancer: Self‐Normalized Detection of ANXA3 from Untreated Urine of Prostate Cancer Patients without Digital Rectal Examination (Adv. Healthcare Mater. 17/2017),Advanced Healthcare Materials

当前位置： X-MOL 学术 › Adv. Healthcare Mater. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prostate Cancer: Self‐Normalized Detection of ANXA3 from Untreated Urine of Prostate Cancer Patients without Digital Rectal Examination (Adv. Healthcare Mater. 17/2017)
Advanced Healthcare Materials ( IF 10.0 ) Pub Date : 2017-09-06 , DOI: 10.1002/adhm.201770092
Minhong Jeun ₁ , Sungwook Park _{1,

2} , Yongdeok Kim ₁ , Jaewon Choi _{1,

2} , Sang Hoon Song ₃ , In Gab Jeong ₃ , Choung-Soo Kim ₃ , Kwan Hyi Lee _{1,

2}

Affiliation

In article number 1700449, Kwan Hyi Lee and co‐workers describe an ion‐responsive urine sensor for analyzing minuscule amounts of prostate cancer biomarkers. Patients' untreated urine samples are loaded onto the sensor, and the resulting signals are proportional to the amount of the urine cancer biomarker within the patients' urine. The resulting signals are also confirmed to be proportional to the size of the tumor volume measured from patients' magnetic resonance images.

中文翻译：

前列腺癌：未经数字化直肠检查的未经治疗的前列腺癌患者尿液中ANXA3的自我标准化检测（Adv。Healthcare Mater。17/2017）

Kwan Hyi Lee及其同事在文章1700449中描述了一种离子敏感型尿液传感器，用于分析微量的前列腺癌生物标记物。将患者未经处理的尿液样本加载到传感器上，结果信号与患者尿液中尿液癌生物标记物的数量成比例。还确认了所得信号与从患者的磁共振图像测得的肿瘤体积大小成正比。

更新日期：2017-09-06

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11